The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Acute Lymphoblastic Leukemia.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Anti-CD19 CAR-transduced T cells (Primary) ; Cyclophosphamide; Fludarabine
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions
- 11 Oct 2016 New trial record